North America Biosimilars Market Size, Statistics, Growth Potentials, Trends 2028


The North America Biosimilars Market is expected to grow from US$ 7,115.74 million in 2022 to US$ 47,746.80 million by 2028. It is estimated to grow at a CAGR of 37.3% from 2022 to 2028.

Growing Prevalence of Chronic Diseases Fuels North America Biosimilars Market

The rising incidence of chronic diseases, key driver of the North America Biosimilars Market. Factors such as an aging population, evolving social behaviors, and the increasing adoption of sedentary lifestyles due to rapid urbanization have contributed to a surge in conditions like obesity and diabetes. Genetic predisposition also plays a significant role in chronic illnesses, including cardiovascular diseases (CVDs), diabetes, Alzheimer’s disease (AD), and depression. According to the National Council on Aging, 80% of adults aged 65 and older have at least one chronic condition, with 68% experiencing two or more. Additionally, the Centers for Disease Control and Prevention (CDC) reported in 2020 that nearly six in ten Americans had at least one chronic disease, while four in ten suffered from two or more.

Cardiovascular diseases such as atherosclerosis, angina pectoris, and acute myocardial infarction are leading causes of mortality worldwide, exacerbated by high-stress lifestyles. The World Health Organization (WHO) estimates that CVDs account for 17.9 million deaths annually, making them the top global cause of death. Meanwhile, diabetes remains a major health concern with no functional cure, often leading to severe complications such as heart attacks, strokes, kidney failure, amputations, vision loss, and nerve damage. According to the International Diabetes Federation (IDF), diabetes cases in North America are projected to rise from 46 million in 2017 to 62 million by 2045. Globally, diabetes cases are expected to grow from 425 million in 2017 to 629 million in 2045, representing a 35% increase in prevalence over the forecast period.

North America Biosimilars Market Segments Covered

North America Biosimilars Market By Disease Indication

  • Cancer
  • Diabetes
  • Autoimmune Diseases
  • Other Diseases

North America Biosimilars Market By Drug Class

  • Granulocyte Colony-Stimulating Factors
  • Human Growth Hormone
  • Insulin
  • TNF Blockers & Monoclonal Antibodies
  • Erythropoietin-Stimulating Agents

North America Biosimilars Market By Route of Administration

  • Intravenous
  • Subcutaneous

North America Biosimilars Market By End User

  • Hospitals
  • Speciality Clinics
  • Homecare

North America Biosimilars Market Regions and Countries Covered

North America

  • US
  • Canada
  • Mexico

North America Biosimilars Market leaders and key company profiles

  • Amgen Inc
  • Celltrion Inc
  • Sanofi SA
  • Biocon Ltd
  • Coherus BioSciences Inc
  • Eli Lilly and Co
  • Sandoz AG
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Dr. Reddy's Laboratories Ltd

North America Biosimilars Market Overview

Autoimmune diseases are also on the rise, further expanding the need for biosimilars. In 2019, the NIH Autoimmune Diseases Coordinating Committee reported that over 24 million Americans were affected by autoimmune diseases, with an additional 8 million showing auto-antibodies—biomarkers that indicate a higher risk of developing such conditions. Research from the National Institute of Environmental Health Sciences (NIEHS) in 2020 highlighted a significant increase in the prevalence of antinuclear antibodies (ANA), the most common biomarker for autoimmunity, across diverse demographics in the U.S.

Biosimilars are increasingly used to treat cancers, kidney diseases, diabetes, and autoimmune conditions such as rheumatoid arthritis and Crohn’s disease. According to Cardinal Health, the FDA has approved 33 biosimilars in the U.S., with 21 commercially available. Of these, 17 are used in cancer treatment, three target autoimmune conditions, and one addresses diabetes.

Strategic Insights into the North America Biosimilars Market

Strategic analysis of the North America biosimilars market provides valuable insights into industry trends, key players, and regional dynamics. A data-driven approach enables businesses to identify untapped market segments and craft unique value propositions to gain a competitive edge. By leveraging analytics, stakeholders—including investors, manufacturers, and healthcare providers—can anticipate market shifts and align their strategies for long-term success. A forward-looking perspective is crucial in this evolving landscape, allowing industry players to make informed decisions, maximize profitability, and achieve their business objectives within the growing biosimilars sector.

Other Reports:

North America Small Satellite Market: https://sites.google.com/view/northamericasmallsatellitemark/home 

North America Hydrocephalus Shunts Market: https://business-news-insights.blogspot.com/2025/04/north-america-hydrocephalus-shunts.html 

North America Airway Management Devices Market: https://postyourarticle.com/north-america-airway-management-devices-market-significant-growth-technological-advancement-2028/ 

North America Ammunition Market: https://businessnews46.wordpress.com/2025/04/01/north-america-ammunition-market-trends-opportunities-by-2028/ 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Post a Comment

Popular posts from this blog

North America Small Satellite Market Trends, Opportunity and Forecast 2022 to 2028

Image
The  North America Small Satellite Market  is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Growing Support for Small Satellite Development Governments and companies across North America are increasingly investing in the small satellite market to meet the growing demand for applications such as Earth observation, communication, navigation, and scientific research. In November 2021, Fleet Space Technologies secured $26 million in funding to expand its nanosatellite IoT connectivity fleet. Such investments from both public and private sectors are fueling market growth. Small satellites play a crucial role in enhancing national security, monitoring disaster-affected areas, tracking suspicious maritime activities, and supporting communication and scientific research. To further boost the industry, governments are promoting initiatives for rapid construction and domestic production o...
Read more

Europe Bathroom Vanities Market Key Players Analysis, Forecast 2028

Image
The  Europe Bathroom Vanities Market  is expected to grow from US$ 14,065.11 million in 2021 to US$ 17,057.14 million by 2028. It is estimated to surge at a CAGR of 2.8% from 2021 to 2028. Growth of Online Retailing in Europe Bathroom Vanities Market The rise of online retailing is significantly driving the expansion of the Europe Bathroom Vanities Market. Consumers are increasingly shifting from traditional purchasing methods to virtual shopping due to the convenience it offers and its broader reach. Advancements in telecommunication infrastructure have made the Internet more accessible, enabling a growing number of users to explore and purchase bathroom vanities online. Online shopping platforms provide consumers with a wide selection of products, complete with detailed specifications and price comparisons. The seamless, end-to-end buying process eliminates the need for physical effort or travel, saving time while enhancing the shopping experience. This shift toward digital ...
Read more

Europe Helicopters Market SWOT Analysis, Size, Share, Trends, Growth and Forecast 2028

Image
The   Europe Helicopters Market   is expected to grow from US$ 10,443.48 million in 2021 to US$ 16,383.49 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. Increasing development of unmanned helicopters and use of advanced materials and technology will accelerate the market growth. Unmanned helicopters are intended to support both civilian and security missions. They are also capable of delivering cargo to hard-to-reach areas without airfields. The ILX-27 is unmanned helicopter developed by Institute of Aviation in Warsaw and Air Force Institute of Technology (AFIT) – Polish scientific and research organization. Europe Helicopters Market Segmentation Europe Helicopters Market - By Type Single Rotor Multi Rotor Tilt Rotor  Europe Helicopters Market -By Weight Light Weight Medium Weight Heavy Weight Europe Helicopters Market -By Application Commercial & Civil Transport Emergency Rescue Utility  Training Military Attack and Reconnaissance...
Read more